Larson Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Larson Financial Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.54K	Sell	32 -3	-9%	-$701	﹤0.01%	2503
2026 Q1	$8.01K	Buy	35 +11	+46%	+$2.47K	﹤0.01%	2365
2025 Q4	$5.12K	Buy	24 +19	+380%	+$3.92K	﹤0.01%	2454
2025 Q3	$994	Buy	+5	New	+$933	﹤0.01%	2925
2025 Q2	–	Sell	-9	Closed	-$1.4K	–	3288
2025 Q1	$1.4K	Buy	+9	New	+$1.29K	﹤0.01%	2283

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Larson Financial Group's ASND Position: Q2 2026 in Review

Larson Financial Group reduced its Ascendis Pharma A/S (ASND) stake by 8.6% in Q2 2026, selling an estimated $701 and leaving 32 shares worth $8.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2503.

Larson Financial Group first reported a position in ASND in Q1 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Larson Financial Group held 32 shares of Ascendis Pharma A/S worth $8.54K as of Q2 2026.
Larson Financial Group sold 3 Ascendis Pharma A/S shares in Q2 2026, an estimated $701.
Ascendis Pharma A/S made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2503 holding.
Larson Financial Group first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 5 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.